Ameritas Investment Company’s VanEck Biotech ETF BBH Stock Holding History

Ameritas Investment Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-371	Closed	-$65.1K	–	837
2021 Q1	$65.1K	Buy	+371	New	+$67.1K	0.01%	884
2020 Q2	–	Sell	-371	Closed	-$48K	–	437
2020 Q1	$48K	Buy	+371	New	+$50K	0.01%	712
2019 Q4	–	Sell	-150	Closed	-$18K	–	902
2019 Q3	$18K	Buy	+150	New	+$18.7K	﹤0.01%	949
2019 Q2	–	Sell	-458	Closed	-$59K	–	283
2019 Q1	$59K	Buy	458 +87	+23%	+$11K	0.01%	412
2018 Q4	$41K	Buy	+371	New	+$44.8K	0.01%	630

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Ameritas Investment Company's BBH Position: Q2 2021 in Review

Ameritas Investment Company sold out of VanEck Biotech ETF (BBH) in Q2 2021, closing a stake of 371 shares — an estimated $65.1K sold.

Ameritas Investment Company first reported a position in BBH in Q4 2018 and held it in 5 quarters. The position peaked at $65.1K in Q1 2021. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2021.

Ameritas Investment Company reported no remaining VanEck Biotech ETF position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 371 VanEck Biotech ETF shares in Q2 2021, an estimated $65.1K.
Ameritas Investment Company first reported a position in VanEck Biotech ETF in Q4 2018 and held it in 5 quarters.
Ameritas Investment Company's VanEck Biotech ETF position peaked at $65.1K in Q1 2021.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.